Invasive Mold Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-22
Clinical Trial Update: A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. [Phase 3]
A Phase 3 clinical trial evaluating Fosmanogepix for invasive mold infections is currently recruiting.